Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 174

1.

Investigation and molecular mimicry of the antigen involved in the interaction between the monoclonal antibody 5D10 and the human breast cancer cell line MCF-7.

Vandevyver C, Canarelli S, Bossen C, Fisch I, Motmans K, Raus J, Freitag R.

Biotechnol Bioeng. 2007 Jul 1;97(4):721-34.

PMID:
17161001
[PubMed - indexed for MEDLINE]
2.

T-cell-based immunotherapy in multiple sclerosis: induction of regulatory immune networks by T-cell vaccination.

Hellings N, Raus J, Stinissen P.

Expert Rev Clin Immunol. 2006 Sep;2(5):705-16. doi: 10.1586/1744666X.2.5.705.

PMID:
20477626
[PubMed]
3.

Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.

Venken K, Hellings N, Hensen K, Rummens JL, Medaer R, D'hooghe MB, Dubois B, Raus J, Stinissen P.

J Neurosci Res. 2006 Jun;83(8):1432-46.

PMID:
16583400
[PubMed - indexed for MEDLINE]
4.

Impaired activation-induced telomerase activity in PBMC of early but not chronic rheumatoid arthritis patients.

Thewissen M, Linsen L, Geusens P, Raus J, Stinissen P.

Immunol Lett. 2005 Sep 15;100(2):205-10. Epub 2005 Apr 7.

PMID:
16154497
[PubMed - indexed for MEDLINE]
5.

Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients.

Thewissen M, Linsen L, Somers V, Geusens P, Raus J, Stinissen P.

Ann N Y Acad Sci. 2005 Jun;1051:255-62.

PMID:
16126966
[PubMed - indexed for MEDLINE]
6.

Peripheral blood but not synovial fluid natural killer T cells are biased towards a Th1-like phenotype in rheumatoid arthritis.

Linsen L, Thewissen M, Baeten K, Somers V, Geusens P, Raus J, Stinissen P.

Arthritis Res Ther. 2005;7(3):R493-502. Epub 2005 Feb 18.

PMID:
15899036
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Parity-induced changes in global gene expression in the human mammary gland.

Verlinden I, Güngör N, Wouters K, Janssens J, Raus J, Michiels L.

Eur J Cancer Prev. 2005 Apr;14(2):129-37.

PMID:
15785316
[PubMed - indexed for MEDLINE]
8.

Protein biomarkers for breast cancer prevention.

Janssens JP, Verlinden I, Güngör N, Raus J, Michiels L.

Eur J Cancer Prev. 2004 Aug;13(4):307-17. Review.

PMID:
15554559
[PubMed - indexed for MEDLINE]
9.

Microdissection and SAGE as a combined tool to reveal gene expression in ductal carcinoma in situ of the breast.

Verlinden I, Janssens J, Raus J, Michiels L.

Mol Carcinog. 2004 Dec;41(4):197-206.

PMID:
15486950
[PubMed - indexed for MEDLINE]
10.

Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand mRNA expression in patients with rheumatoid arthritis and healthy controls.

Vanderborght A, Linsen L, Thewissen M, Geusens P, Raus J, Stinissen P.

J Rheumatol. 2004 Aug;31(8):1483-90.

PMID:
15290725
[PubMed - indexed for MEDLINE]
11.

T-cell vaccination in multiple sclerosis: update on clinical application and mode of action.

Hellings N, Raus J, Stinissen P.

Autoimmun Rev. 2004 Jun;3(4):267-75. Review.

PMID:
15246022
[PubMed - indexed for MEDLINE]
12.

Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients.

Dumont D, Noben JP, Raus J, Stinissen P, Robben J.

Proteomics. 2004 Jul;4(7):2117-24.

PMID:
15221773
[PubMed - indexed for MEDLINE]
13.

Cytokine-induced cell death in human oligodendroglial cell lines. II: Alterations in gene expression induced by interferon-gamma and tumor necrosis factor-alpha.

Buntinx M, Gielen E, Van Hummelen P, Raus J, Ameloot M, Steels P, Stinissen P.

J Neurosci Res. 2004 Jun 15;76(6):846-61.

PMID:
15160396
[PubMed - indexed for MEDLINE]
14.

Cytokine-induced cell death in human oligodendroglial cell lines: I. Synergistic effects of IFN-gamma and TNF-alpha on apoptosis.

Buntinx M, Moreels M, Vandenabeele F, Lambrichts I, Raus J, Steels P, Stinissen P, Ameloot M.

J Neurosci Res. 2004 Jun 15;76(6):834-45.

PMID:
15160395
[PubMed - indexed for MEDLINE]
15.

Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury: morphology and oligodendrocyte-specific gene expression.

Buntinx M, Vanderlocht J, Hellings N, Vandenabeele F, Lambrichts I, Raus J, Ameloot M, Stinissen P, Steels P.

J Neurocytol. 2003 Jan;32(1):25-38.

PMID:
14618099
[PubMed - indexed for MEDLINE]
16.

Immune-mediated oligodendrocyte injury in multiple sclerosis: molecular mechanisms and therapeutic interventions.

Buntinx M, Stinissen P, Steels P, Ameloot M, Raus J.

Crit Rev Immunol. 2002;22(5-6):391-424. Review.

PMID:
12803318
[PubMed - indexed for MEDLINE]
17.

Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls.

Van der Aa A, Hellings N, Bernard CC, Raus J, Stinissen P.

J Neuroimmunol. 2003 Apr;137(1-2):164-76.

PMID:
12667661
[PubMed - indexed for MEDLINE]
18.

T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot study.

Van der Aa A, Hellings N, Medaer R, Gelin G, Palmers Y, Raus J, Stinissen P.

Clin Exp Immunol. 2003 Jan;131(1):155-68.

PMID:
12519400
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

A high-performance liquid chromatography/tandem mass spectrometric screening method for eight synthetic corticosteroids in bovine feces and the simultaneous differentiation between dexamethasone and betamethasone.

Noben JP, Gielen B, Royackers E, Missotten M, Jacobs A, Raus J.

Rapid Commun Mass Spectrom. 2002;16(16):1590-4.

PMID:
12203252
[PubMed - indexed for MEDLINE]
20.

The relationship among history of falls, osteoporosis, and fractures in postmenopausal women.

Geusens P, Autier P, Boonen S, Vanhoof J, Declerck K, Raus J.

Arch Phys Med Rehabil. 2002 Jul;83(7):903-6.

PMID:
12098147
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk